ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Also in This 8-page Issue: President Bush Nominates EPA Administrator Michael Leavitt for HHS Secretary.

January 7, 2005

Funding Opportunities (12-page issue).

May 16, 2003

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995